Understanding the age-related impairments in these adaptive mechanisms highlights the need for therapeutic strategies that enhance IGF-1 signaling to maintain cerebrovascular health and prevent the adverse effects of hypertension in the aging population. This evidence concerns the gene IGF1 and hypertensive disorder.